Boston Sci, J&J Bury The Hatchet In Guidant Acquisition Dispute
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will pay Johnson & Johnson $600 million to settle allegations that cardiovascular device firm Guidant breached a merger agreement with J&J in 2006, a far cry from the $7 billion sought by J&J
You may also be interested in...
Boston Sci Ups Urology Focus With $1.6 Billion AMS Deal
The firm is expanding its leadership position in the urology space with its acquisition of American Medical Systems's men's health and prostate health units.
Boston Scientific, Guidant Close The Deal Following FTC Approval
Boston Scientific closed its $28 bil. acquisition of Guidant on April 21, one day after the Federal Trade Commission approved the deal - the largest medical device acquisition in history